Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


Strengths

● The prospective high growth for the next fiscal years is among the main assets of the company

● The company's profit outlook over the next few years is a strong asset.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.


Weaknesses

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 66.55 times its estimated earnings per share for the ongoing year.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last few months, analysts have been revising downwards their earnings forecast.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.